Gabay Avraham 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Gabay Avraham
Chief Financial Officer
Transactions
- Award
Common Stock
2025-01-02+188,000→ 358,040 total
Footnotes (1)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 15,666 over a three year period starting January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.